Sandrine Opi

1.4k total citations
28 papers, 1.1k citations indexed

About

Sandrine Opi is a scholar working on Virology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Sandrine Opi has authored 28 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Virology, 14 papers in Infectious Diseases and 13 papers in Molecular Biology. Recurrent topics in Sandrine Opi's work include HIV Research and Treatment (21 papers), HIV/AIDS drug development and treatment (14 papers) and Immune Cell Function and Interaction (6 papers). Sandrine Opi is often cited by papers focused on HIV Research and Treatment (21 papers), HIV/AIDS drug development and treatment (14 papers) and Immune Cell Function and Interaction (6 papers). Sandrine Opi collaborates with scholars based in France, United States and China. Sandrine Opi's co-authors include Klaus Strebel, Eri Miyagi, Ritu Goila-Gaur, Sandra Kao, Hiroaki Takeuchi, Mohammad A. Khan, Erwann Loret, Didier Esquieu, Grant R. Campbell and Yves Collette and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Molecular and Cellular Biology.

In The Last Decade

Sandrine Opi

28 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandrine Opi France 18 857 505 469 339 299 28 1.1k
Erwann Le Rouzic France 21 959 1.1× 824 1.6× 569 1.2× 254 0.7× 359 1.2× 28 1.5k
Adam Gates United States 11 509 0.6× 622 1.2× 386 0.8× 238 0.7× 185 0.6× 13 1.2k
Reem Berro United States 18 666 0.8× 611 1.2× 344 0.7× 123 0.4× 342 1.1× 21 1.1k
Richard D. Sloan Canada 21 785 0.9× 377 0.7× 650 1.4× 278 0.8× 292 1.0× 37 1.2k
Amy J. Andrew United States 13 432 0.5× 577 1.1× 149 0.3× 268 0.8× 237 0.8× 18 1.1k
Erica Stec United States 7 353 0.4× 577 1.1× 209 0.4× 118 0.3× 145 0.5× 9 884
Venkat S. R. K. Yedavalli United States 11 530 0.6× 996 2.0× 283 0.6× 150 0.4× 279 0.9× 13 1.4k
Thomas Fricke United States 14 1.0k 1.2× 627 1.2× 663 1.4× 255 0.8× 240 0.8× 23 1.3k
Zhihai Si United States 17 1.1k 1.3× 553 1.1× 528 1.1× 319 0.9× 558 1.9× 19 1.4k
Ashwanth C. Francis United States 16 785 0.9× 432 0.9× 523 1.1× 176 0.5× 145 0.5× 27 1.0k

Countries citing papers authored by Sandrine Opi

Since Specialization
Citations

This map shows the geographic impact of Sandrine Opi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandrine Opi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandrine Opi more than expected).

Fields of papers citing papers by Sandrine Opi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandrine Opi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandrine Opi. The network helps show where Sandrine Opi may publish in the future.

Co-authorship network of co-authors of Sandrine Opi

This figure shows the co-authorship network connecting the top 25 collaborators of Sandrine Opi. A scholar is included among the top collaborators of Sandrine Opi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandrine Opi. Sandrine Opi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Xiaoli, S. Betzi, Adrien Lugari, et al.. (2012). Structural recognition mechanisms between human Src homology domain 3 (SH3) and ALG‐2‐interacting protein X (Alix). FEBS Letters. 586(13). 1759–1764. 6 indexed citations
2.
Lugari, Adrien, Sebastian Breuer, Thibault Coursindel, et al.. (2011). A specific protein disorder catalyzer of HIV-1 Nef. Bioorganic & Medicinal Chemistry. 19(24). 7401–7406. 4 indexed citations
3.
Shi, Xiaoli, Sandrine Opi, Adrien Lugari, et al.. (2010). Identification and biophysical assessment of the molecular recognition mechanisms between the human haemopoietic cell kinase Src homology domain 3 and ALG-2-interacting protein X. Biochemical Journal. 431(1). 93–102. 9 indexed citations
4.
Paronetto, Maria Paola, Sandrine Opi, Stéphane Audebert, et al.. (2009). Alternative Splicing Modulates Autoinhibition and SH3 Accessibility in the Src Kinase Fyn. Molecular and Cellular Biology. 29(24). 6438–6448. 28 indexed citations
5.
Miyagi, Eri, Sandrine Opi, Hiroaki Takeuchi, et al.. (2007). Enzymatically Active APOBEC3G Is Required for Efficient Inhibition of Human Immunodeficiency Virus Type 1. Journal of Virology. 81(24). 13346–13353. 129 indexed citations
6.
Betzi, S., Audrey Restouin, Sandrine Opi, et al.. (2007). Protein–protein interaction inhibition (2P2I) combining high throughput and virtual screening: Application to the HIV-1 Nef protein. Proceedings of the National Academy of Sciences. 104(49). 19256–19261. 85 indexed citations
7.
Goila-Gaur, Ritu, Mohammad A. Khan, Eri Miyagi, et al.. (2007). HIV-1 Vif promotes the formation of high molecular mass APOBEC3G complexes. Virology. 372(1). 136–146. 38 indexed citations
8.
Kao, Sandra, Ritu Goila-Gaur, Eri Miyagi, et al.. (2007). Production of infectious virus and degradation of APOBEC3G are separable functional properties of human immunodeficiency virus type 1 Vif. Virology. 369(2). 329–339. 31 indexed citations
9.
Khan, Mohammad A., Ritu Goila-Gaur, Sandrine Opi, et al.. (2007). Analysis of the contribution of cellular and viral RNA to the packaging of APOBEC3G into HIV-1 virions. Retrovirology. 4(1). 48–48. 66 indexed citations
10.
Campbell, Grant R., Jennifer Watkins, Didier Esquieu, et al.. (2007). Tat mutations in an African cohort that do not prevent transactivation but change its immunogenic properties. Vaccine. 25(50). 8441–8447. 11 indexed citations
11.
Watkins, Jennifer, Sophie Lancelot, Grant R. Campbell, et al.. (2006). Reservoir cells no longer detectable after a heterologous SHIV challenge with the synthetic HIV-1 Tat Oyi vaccine. Retrovirology. 3(1). 8–8. 22 indexed citations
12.
Carré, Manon, Pascale Barbier, Grant R. Campbell, et al.. (2005). HIV-1 Tat protein enhances Microtubule polymerization. Retrovirology. 2(1). 5–5. 48 indexed citations
13.
Kao, Sandra, Eri Miyagi, Mohammad A. Khan, et al.. (2004). Production of infectious human immunodeficiency virus type 1 does not require depletion of APOBEC3G from virus-producing cells. Retrovirology. 1(1). 27–27. 86 indexed citations
14.
Opi, Sandrine, Jean‐Marie Péloponèse, Didier Esquieu, et al.. (2004). Full-length HIV-1 Tat protein necessary for a vaccine. Vaccine. 22(23-24). 3105–3111. 22 indexed citations
15.
Vo‐Thanh, Giang, Valérie Fargeas, Didier Dubreuil, et al.. (2004). A possible improvement for structure-based drug design illustrated by the discovery of a Tat HIV-1 inhibitor. Bioorganic & Medicinal Chemistry Letters. 14(6). 1543–1546. 10 indexed citations
16.
Esquieu, Didier, Jean‐Marie Péloponèse, Sandrine Opi, et al.. (2003). Discovery of a Tat HIV‐1 Inhibitor through Computer‐Aided Drug Design. Journal of Spectroscopy. 17(4). 639–645. 6 indexed citations
17.
Luccio, Eric di, Alessandra Matavel, Sandrine Opi, et al.. (2002). Evolution of maurotoxin conformation and blocking efficacy towards Shaker B channels during the course of folding and oxidation in vitro. Biochemical Journal. 361(2). 409–409. 6 indexed citations
18.
Opi, Sandrine, Jean‐Marie Péloponèse, Didier Esquieu, et al.. (2002). Tat HIV-1 Primary and Tertiary Structures Critical to Immune Response Against Non-homologous Variants. Journal of Biological Chemistry. 277(39). 35915–35919. 34 indexed citations
19.
Grégoire, Catherine, Jean‐Marie Péloponèse, Didier Esquieu, et al.. (2001). Homonuclear 1H‐NMR assignment and structural characterization of human immunodeficiency virus type 1 Tat Mal protein. Biopolymers. 62(6). 324–335. 42 indexed citations
20.
Péloponèse, Jean‐Marie, Catherine Grégoire, Sandrine Opi, et al.. (2000). 1H-13C nuclear magnetic resonance assignment and structural characterization of HIV-1 Tat protein. Comptes Rendus de l Académie des Sciences - Series III - Sciences de la Vie. 323(10). 883–894. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erwann Le Rouzic Breakdown of academic impact, for papers by Adam Gates Breakdown of academic impact, for papers by Reem Berro Breakdown of academic impact, for papers by Richard D. Sloan Breakdown of academic impact, for papers by Amy J. Andrew Breakdown of academic impact, for papers by Erica Stec Breakdown of academic impact, for papers by Venkat S. R. K. Yedavalli Breakdown of academic impact, for papers by Thomas Fricke Breakdown of academic impact, for papers by Zhihai Si Breakdown of academic impact, for papers by Ashwanth C. Francis
Rankless by CCL
2026